This study found that the dramatic shift from face-to-face posthospital transitional care to telehealth did not affect 30-day readmission or mortality during the COVID-19 pandemic.
Cheng-Wei Huang, MD
Advertisement
Articles by Cheng-Wei Huang, MD
Development and Validation of the COVID-19 Hospitalized Patient Deterioration Index
ByClaudia Nau, PhD,Rebecca K. Butler, ScM,Cheng-Wei Huang, MD,Vang Kou Khang, MD,Aiyu Chen, MPH,Beth Creekmur, MA,Benjamin Broder, MD, PhD,Christopher Subject, MD,Adam L. Sharp, MD, MSc,Luis M. Moreta-Sainz, MD,Joon S. Park, MD,Akshay J. Manek, MD,Robert M. Cooper, MD,Sergio M. Mendoza, MD,Gang Luo, PhD,Michael K. Gould, MD, MS
The authors developed and validated an accurate, well-calibrated, easy-to-implement COVID-19 hospitalized patient deterioration index to identify patients at high or low risk of clinical deterioration.
Advertisement
Latest Updated Articles
Telehealth Transitional Care and 30-Day Readmission During the COVID-19 PandemicPublished: January 15th 2024 | Updated:
- Development and Validation of the COVID-19 Hospitalized Patient Deterioration Index
Published: December 22nd 2023 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
2
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
3
GLP-1 Receptor Agonists May Improve Rheumatoid Arthritis Symptoms
4
Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD
5
